Contract Manufacturing Industry News
-
Abbott Announces New Test For The Management Of Patients With Diabetes
7/10/2012
More than 346 million people worldwide are living with diabetes, and the World Diabetes Foundation estimates that number will increase by nearly 27 percent by 2030. In order to help physicians appropriately monitor treatment efficacy for these patients, Abbott announced recently CE Marking (Conformité Européenne) for the Abbott ARCHITECT HbA1c (IA) Assay.
-
CPhI's Upcoming Conference Focuses On Advances In Pharma And Biopharma Drug Delivery
6/28/2012
The NextGen India 2012: Advances in Pharma and Biopharma Drug Delivery conference will be held on July 25-27 in Mumbai. This conference will focus on bringing practical case studies from concept to commercialisation stages including orals, injectables, liposomes, sustained release depots, nanotechnology and solubility enhancing techniques.
-
Catalent And Bend Research Partner To Provide Integrated Solutions For Oral Controlled-Release Technologies
6/21/2012
Catalent Pharma Solutions, Inc. and Bend Research Inc. have entered into an agreement to provide integrated solutions for pharmaceutical companies seeking to develop and manufacture specialized multiparticulate oral controlled-release products.
-
CPhI South America 2012 Returns To Brazil With One Of A Kind Pharma Event
6/19/2012
Leading events organiser UBM Live, a division of UBM Plc, recently announced details of the fifth edition of CPhI South America which will take place from 21st to 23rd of August 2012 at the Transamérica Expo Center in São Paulo, Brazil. CPhI South America will once again be co-located with ICSE South America for outsourcing services and BioPh for companies working in biotechnical solutions.
-
DSM Announces Patent Grants For Proprietary XD Biomanufacturing Technology
6/19/2012
DSM Biologics focuses on optimizing biopharmaceutical manufacturing through its unique set of technologies. The XD technology is an important building block in DSM’s vision for the future of biopharmaceutical manufacturing.
-
Dalton Pharma Services Receives GLP Certification
6/18/2012
Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, recently announced that the company has received GLP certification from The Standards Council of Canada.
-
Quintiles Deepens Investment In China
6/18/2012
In a ceremony underscoring the growing importance of China to the global biopharmaceutical industry, Quintiles executives and local dignitaries recently announced agreements to establish a Quintiles regional headquarters for China in Shanghai and to significantly expand lab testing capabilities in China.
-
Vetter Expands Its Capacities And Services For Prefilled Syringes
6/18/2012
The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location.
-
Suzhou Pharma Services Announces New US Corporate Offices In Lyndhurst, NJ And Our FDA Approved And Chinese SFDA Licensed Manufacturing Facility In Suzhou, China
6/15/2012
Suzhou Pharma Services, an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, is proud to announce the location of our new corporate headquarters in Lyndhurst, New Jersey and the company’s primary manufacturing facility located in Suzhou, China.
-
Recipharm Invests In Additional Cartridge Filling Machine For Injectable Solutions
6/7/2012
Recipharm, the international pharmaceutical contract development and manufacturing organization, recently announced that it has invested in a brand new state of the art Dara cartridge filling machine at its modern facility in Monts (Loire Valley, France).